Jayesh Sanmukhani
6PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 24, 2024
A prospective, randomized, parallel, active controlled, phase III Indian study of immunogenicity and safety of two inactivated influenza vaccines - Vaxiflu-4 and Fluarix tetra in children aged 6 months to 35 months.Kairav Kothari, Shreyansh Shah, Vinay Kumar Gill
|Jun 17, 2022
Efficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion.R S Kumar, Manish Kumar Jain, Jitendra Singh Kushwaha
|Jan 26, 2022
Efficacy and safety of avanafil as compared with sildenafil in the treatment of erectile dysfunction: A randomized, double blind, multicenter clinical trial.Manish Kumar, Amey D Pathade, S VijayaBhaskara Gupta
|Aug 27, 2020
Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, multicenter, phase III clinical trial.Sumantra Sarkar, Chandrakant Bokade, Kapil Garg
|Feb 21, 2018
Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial.Shrikant Sharma, Veer Bahadur Singh, Sanjay Kumar
|Apr 01, 2017
Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial.Ashwani Sood, Monjori Mitra, Himanshu Arvind Joshi
Pageof 1
